Purohit, Neha
Gupta, Parul Chawla
Buttan, Sandeep
Chauhan, Akashdeep Singh
Choudhury, Ranjan Kumar
Gupta, Vishali
Kotwal, Atul
Prinja, Shankar https://orcid.org/0000-0001-7719-6986
Funding for this research was provided by:
Bill and Melinda Gates Foundation (INV-064844)
Article History
Accepted: 4 March 2025
First Online: 10 April 2025
Declarations
:
: All authors contributed to the study conception and design. Data collection, analysis and model development were performed by Neha Purohit, Sandeep Buttan, Parul Gupta Chawla, and Akashdeep Singh Chauhan, and were validated by all the authors. Neha Purohit drafted the manuscript, and all authors provided comments on earlier versions. Shankar Prinja obtained the funding for the study. All authors reviewed and approved the final manuscript.
: The work is supported by grant (INV-064844) from the Bill and Melinda Gates Foundation for conducting this study. The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
: Shankar Prinja is an editorial board member of PharmacoEconomics Open. Shankar Prinja was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. All the other co-authors declare no conflict of interest.
: All the sources of secondary data used for analysis have been provided in the electronic supplementary material. Primary data related to determination of utility values in patients with diabetic retinopathy can be shared upon written request to the corresponding author, after removal of all personal identifiers to ensure participant privacy.
: The research study was approved by the Institutional Ethics Committee, Post Graduate Institute of Medical Education and Research, Chandigarh, India, vide reference no. PGI/IEC/2024/1599.
: Consent for participation was provided by the patients with diabetic retinopathy who were interviewed for evaluation of quality of life.
: Consent for publication was provided by the patients with diabetic retinopathy who were interviewed for evaluation of quality of life.
: The Excel model is available as an open access model at the Global Health CEA registry and can be accessed at .